Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BYDUREON vs CABOZANTINIB S-MALATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BYDUREON vs CABOZANTINIB S-MALATE: Safety Overview

Metric BYDUREON CABOZANTINIB S-MALATE
Total FAERS Reports 1,593 39,270
Deaths Reported 11 4,203
Death Rate 0.7% 10.7%
Hospitalizations 70 6,193
Average Patient Age 59.9 yrs 65.0 yrs
% Female Patients N/A 29.9%
FDA Approval Date N/A Apr 25, 2016
Manufacturer N/A Exelixis, Inc.
Route N/A ORAL
Marketing Status N/A Prescription